Lifetime Care of Duchenne Muscular Dystrophy
- PMID: 33131659
- PMCID: PMC7534837
- DOI: 10.1016/j.jsmc.2020.08.011
Lifetime Care of Duchenne Muscular Dystrophy
Abstract
Individuals with Duchenne muscular dystrophy (DMD) have evolving sleep and respiratory pathophysiology over their lifetimes. Across the lifespan of DMD, various sleep-related breathing disorders (SRBD) have been described, including obstructive sleep apnea, central sleep apnea, and nocturnal hypoventilation. In addition to SRBD, individuals with DMD can be affected by insomnia, chronic pain and other factors interfering with sleep quality, and daytime somnolence. The natural progression of DMD pathophysiology has changed with the introduction of therapies for downstream pathologic pathways and will continue to evolve with the development of therapies that target function and expression of dystrophin.
Keywords: Duchenne muscular dystrophy; Insomnia hypoventilation; Neuromuscular disease; Noninvasive ventilation; Obstructive sleep apnea; Polysomnogram; Respiratory failure.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr E.W. MacKintosh has no relevant disclosures.
Figures
References
-
- Verhaart I.E.C., Aartsma-Rus A. Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol. 2019;15:373–386. - PubMed
-
- Janssen M.M.H.P., Bergsma A., Geurts A.C.H. Patterns of decline in upper limb function of boys and men with DMD: an international survey. J Neurol. 2014;261:1269–1288. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
